secwatch.observer — SEC 8-K summary
======================================

Issuer:     MAXCYTE, INC. (MXCT)
CIK:        0001287098
Form:       8-K
Filed at:   2025-06-18T23:59:59+00:00
Accession:  0001558370-25-008730
Event type: other
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02, 5.07, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Shareholders approve 2.95M share increase under MaxCyte 2022 Equity Plan; AIM delisting also approved
--------------------------------------------------------------------------------

- Stockholders approved Amended 2022 Plan, increasing share reserve by 2,950,000 shares (74.1M for, 6.5M against).
- Proposal to cancel admission to AIM London Stock Exchange passed with 82.9M votes in favor.
- Elected Class I directors: Maher Masoud (69.8M for), Yasir Al-Wakeel (58.9M), Rekha Hemrajani (59.1M).
- Ratified CohnReznick LLP as independent auditor for fiscal year 2025 (87.0M for).
- Adjournment proposal deemed moot as all other proposals passed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1287098/000155837025008730/0001558370-25-008730-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1287098/000155837025008730/mxct-20250618x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-25-008730

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer